Total tumor burden in lymphoma – an evolving strong prognostic parameter
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Total tumor burden in lymphoma – an evolving strong prognostic parameter
Authors
Keywords
-
Journal
BRITISH JOURNAL OF RADIOLOGY
Volume -, Issue -, Pages 20210448
Publisher
British Institute of Radiology
Online
2021-08-12
DOI
10.1259/bjr.20210448
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High total metabolic tumor volume at baseline allows discrimination of survival even in patients aged 60 to 80 years responding to R-CHOP
- (2020) Laetitia Vercellino et al. BLOOD
- Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies
- (2020) Bouthaina Shbib Dabaja et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines
- (2020) Andrew Wirth et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma
- (2020) Bouthaina Shbib Dabaja et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Deep learning FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma
- (2020) Nicolò Capobianco et al. JOURNAL OF NUCLEAR MEDICINE
- High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era
- (2020) Pablo Mozas et al. LEUKEMIA RESEARCH
- Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome
- (2020) Karin Nielsen et al. RADIOTHERAPY AND ONCOLOGY
- Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma
- (2020) Frederick L. Locke et al. Blood Advances
- Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT†
- (2020) A.-S. Cottereau et al. ANNALS OF ONCOLOGY
- Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status
- (2020) Diamantis I. Tsilimigras et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- The optimal use of imaging in Radiation Therapy for lymphoma – Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)
- (2019) N.George Mikhaeel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Time to prepare for risk adaptation in lymphoma by standardising measurement of metabolic tumour burden
- (2019) Sally F. Barrington et al. JOURNAL OF NUCLEAR MEDICINE
- Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors
- (2019) Yoshihiko Sakata et al. Thoracic Cancer
- Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial
- (2019) Christine Schmitz et al. EUROPEAN JOURNAL OF CANCER
- Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial
- (2018) Anne-Ségolène Cottereau et al. BLOOD
- Bigger is not always better: Tumor size and prognosis in advanced melanoma
- (2018) Allison Betof Warner et al. CLINICAL CANCER RESEARCH
- Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group
- (2018) Andrea K. Ng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group
- (2018) Louis S. Constine et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- PET/CT in Radiation Therapy Planning
- (2018) Lena Specht et al. SEMINARS IN NUCLEAR MEDICINE
- Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
- (2018) David M. Kurtz et al. JOURNAL OF CLINICAL ONCOLOGY
- Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?
- (2018) Hajira Ilyas et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evaluation of clinical target volume expansion required for involved site neck radiotherapy for lymphoma to account for the absence of a pre-chemotherapy PET-CT in the radiotherapy treatment position
- (2017) David Bird et al. RADIOTHERAPY AND ONCOLOGY
- Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma
- (2017) Andrea M. Abbott et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)
- (2016) A. S. Cottereau et al. ANNALS OF ONCOLOGY
- Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma
- (2016) A.-S. Cottereau et al. CLINICAL CANCER RESEARCH
- Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
- (2016) N. George Mikhaeel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies
- (2016) Michel Meignan et al. JOURNAL OF CLINICAL ONCOLOGY
- Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma
- (2016) Anne-Ségolène Cottereau et al. JOURNAL OF NUCLEAR MEDICINE
- Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma
- (2015) L. Ceriani et al. BLOOD
- Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: A sub-study of EORTC 10994/BIG 1-00 phase III trial
- (2015) F. Fei et al. EUROPEAN JOURNAL OF CANCER
- The concept and evolution of involved site radiation therapy for lymphoma
- (2015) Lena Specht et al. International Journal of Clinical Oncology
- Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group
- (2015) Joachim Yahalom et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Baseline metabolic tumour volume in Hodgkin lymphoma: the prognostic value of accessory cells
- (2014) Michel Meignan EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients
- (2014) Michel Meignan et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of FDG-PET in the Implementation of Involved-Node Radiation Therapy for Hodgkin Lymphoma Patients
- (2014) Théodore Girinsky et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Prospective Study of 18FDG-PET With CT Coregistration for Radiation Treatment Planning of Lymphomas and Other Hematologic Malignancies
- (2014) Stephanie A. Terezakis et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group
- (2014) Tim Illidge et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor burden in Hodgkin's lymphoma: Much more than the best prognostic factor
- (2013) Paolo G. Gobbi CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)
- (2013) Lena Specht et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma
- (2012) Roberto Iacovelli et al. BJU INTERNATIONAL
- Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy
- (2012) Paolo G Gobbi et al. HEMATOLOGICAL ONCOLOGY
- Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy
- (2012) Paolo G. Gobbi et al. HEMATOLOGICAL ONCOLOGY
- Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters
- (2012) PAOLO G. GOBBI et al. ONCOLOGY REPORTS
- Chemoresistance As a Function of the Pretherapy Tumor Burden and the Chemotherapy Regimen Administered: Differences Observed With 2 Current Chemotherapy Regimens for Advanced Hodgkin Lymphoma
- (2011) Paolo G. Gobbi et al. Clinical Lymphoma Myeloma & Leukemia
- Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features
- (2010) Emilia Montagna et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic factors in Hodgkin's disease stage III with special reference to tumour burden
- (2010) Lena Specht et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Prognostic factors in Hodgkin's disease stage IV
- (2010) Lena Specht et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Hodgkin's disease and age*
- (2010) Lena Specht et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
- (2010) Abigail S. Caudle et al. JOURNAL OF CLINICAL ONCOLOGY
- Elucidation of Relationship Between Tumor Size and Survival in Non-Small-Cell Lung Cancer Patients Can Aid Early Decision Making in Clinical Drug Development
- (2009) Y Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
- The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines
- (2008) Theodore Girinsky et al. RADIOTHERAPY AND ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now